濮阳东方医院看男科技术非常哇塞濮阳市东方医院值得信赖,濮阳东方男科医院割包皮可靠,濮阳东方男科好,濮阳东方妇科口碑怎么样,濮阳东方妇科价格便宜,濮阳东方医院男科收费高不高,濮阳东方价格公开

With Georgia playing a key role in this year’s presidential election, Democrats in the state are reminding voters to check the status of their ballot before a 5 p.m. Friday deadline.Voters in Georgia have until then to “cure” their ballot as the state has a rule that allows people who have their ballot rejected for administrative reasons, such as forgetting a signature, to fix their ballot. Ballots not cured by 5 p.m. Friday are thrown out.Georgia is not the only state that allows for ballot curing. According to the National Association of State Legislatures, 18 states have rules that allow voters to correct errors such as signature discrepancies. While in some states, the deadline to fix such discrepancies has passed, in other states, voters have up to three weeks to fix their ballot depending on the state.Other close states that allow ballot curing include Nevada and Arizona. Nevada gives voters seven days to correct a signature discrepancy. Arizona gives voters five days to make a correction.Pennsylvania is a state that does not have a process for ballot curing. According to WPVI-TV, some counties allowed voters to cure their ballot, prompting a lawsuit from Republicans. According to WPVI, nearly 1,600 voters in Bucks County had their ballot rejected, many for not properly placing their ballot inside of the “secrecy envelope," as voters in Pennsylvania are required to place their ballot inside an unmarked envelope, which is placed inside a marked envelope.In most states that permit ballot curing, elections officials are to notify voters of the discrepancy immediately. But with thousands of ballots being counted, there are questions on whether election officials are able to reach all voters.Stacey Abrams, a prominent Georgia Democrat who had an unsuccessful bid for governor in 2018, launched a website “CheckMyBallot.net” which allows voters in key battleground states to check the status of their mail-in or provisional ballot.What voters aren’t able to do through vote curing is change their vote. 2040

WILLIAMSTOWN, Ky. — Northern Kentucky law enforcement officials are working extra hard this time of year to keep any "Grinchiness" out of their respective "Whovilles."Before Grant County Sheriff’s Deputy Scott Conrad hits the road these days, he arms himself with kindness, in the form of gift cards.“It’s part of the Sheriff's Santa Project,” Conrad said.It’s an idea that was brought to the office three years ago by their chaplain.“I really think projects like this give us a glass-half-full attitude, rather than a glass-half-empty,” Grant County Sheriff’s Office Chaplain Rev. Tim Polley said. “Don’t we all need some joy in our lives?”The answer for Grant County’s deputies is "yes."“We make a legit traffic stop,” Conrad said. “In lieu of writing a citation, we hand out a gift card to our local businesses.”Several drivers who got a Sheriff's Santa surprise were both grateful and thankful, a nice reminder to use a turn signal.The project does more than just promote good driving, it also drives business to local shops and restaurants who could use a customer boost during the coronavirus pandemic.“Typically, we deal with the more negative aspects of humanity, so when we can do anything that's positive, it's a blessing to us,” Conrad said. “We swore an oath to the Constitution. I got into this job 15 years ago 'cause I wanted to help people.”Now he’s helping people by helping to give back to the community.“Everybody thinks they're out to get us, but they're here to help us,” said driver Justin Ost, who got a gift card to a local barbecue restaurant.Polley sought out local businesses to donate the gift cards, or people to donate money to be exchanged into cards. “It is just that little nudge that some people need to say there is still good in this world,” he said.The Sheriff's Santa Project runs through Christmas Eve.This story originally reported by Kristyn Hartman on wcpo.com. 1912

With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune system to make them.Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines work by tricking the body into thinking there’s an infection so it makes antibodies and remembers how to do that if the real bug turns up.But it can take a month or two after vaccination or infection for the most effective antibodies to form. The experimental drugs shortcut that process by giving concentrated versions of specific ones that worked best against the coronavirus in lab and animal tests.“A vaccine takes time to work, to force the development of antibodies. But when you give an antibody, you get immediate protection,” said University of North Carolina virologist Dr. Myron Cohen. “If we can generate them in large concentrations, in big vats in an antibody factory ... we can kind of bypass the immune system.”These drugs are believed to last for a month or more and could give quick, temporary immunity to people at high risk of infection, such as health workers and housemates of someone with COVID-19. If they proved effective and if a vaccine doesn’t materialize or protect as hoped, the drugs might eventually be considered for wider use, perhaps for teachers or other groups.They’re also being tested as treatments, to help the immune system and prevent severe symptoms or death.“The hope there is to target people who are in the first week of their illness and that we can treat them with the antibody and prevent them from getting sick,” said Dr. Marshall Lyon, an infectious disease specialist helping to test one such drug at Emory University in Atlanta.Having such a tool “would be a really momentous thing in our fight against COVID,” Cohen said.Vaccines are seen as a key to controlling the virus, which has been confirmed to have infected more than 20 million people worldwide and killed more than 738,000. Several companies are racing to develop vaccines, but the results of the large final tests needed to evaluate them are months away.The antibody drugs are “very promising” and, in contrast, could be available “fairly soon,” said Dr. Janet Woodcock, a U.S. Food and Drug Administration official who is leading government efforts to speed COVID-19 therapies. Key studies are underway and some answers should come by early fall.One company, Eli Lilly, has already started manufacturing its antibody drug, betting that studies now underway will give positive results.“Our goal is to get something out as soon as possible” and to have hundreds of thousands of doses ready by fall, said Lilly’s chief scientific officer, Dr. Daniel Skovronsky.Another company that developed an antibody drug cocktail against Ebola — Regeneron Pharmaceuticals Inc. — now is testing one for coronavirus.“The success with our Ebola program gives us some confidence that we can potentially do this again,” said Christos Kyratsous, a Regeneron microbiologist who helped lead that work.Regeneron’s drug uses two antibodies to enhance chances the drug will work even if the virus evolves to evade action by one.Lilly is testing two different, single-antibody drugs — one with the Canadian company AbCellera and another with a Chinese company, Junshi Biosciences. In July, Junshi said no safety concerns emerged in 40 healthy people who tried it and that larger studies were getting underway.Others working on antibody drugs include Amgen and Adaptive Biotechnologies. The Singapore biotech company Tychan Pte Ltd. also is testing an antibody drug and has similar products in development for Zika virus and yellow fever.“I’m cautiously optimistic” about the drugs, said the nation’s top infectious diseases expert, Dr. Anthony Fauci. “I’m heartened by the experience that we had with Ebola,” where the drugs proved effective.What could go wrong?— The antibodies may not reach all of the places in the body where they need to act, such as deep in the lungs. All the antibody drugs are given through an IV and must make their way through the bloodstream to wherever they’re needed.— The virus might mutate to avoid the antibody — the reason Regeneron is testing a two-antibody combo that binds to the virus in different places to help prevent its escape.Skovronsky said Lilly stuck with one antibody because manufacturing capacity would essentially be cut in half to make two, and “you will have less doses available.” If a single antibody works, “we can treat twice as many people,” he said.— The antibodies might not last long enough. If they fade within a month, it’s still OK for treatment since COVID-19 illness usually resolves in that time. But for prevention, it may not be practical to give infusions more often than every month or two.A San Francisco company, Vir Biotechnology Inc., says it has engineered antibodies to last longer than they usually do to avoid this problem. GlaxoSmithKline has invested 0 million in Vir to test them.Giving a higher dose also may help. If half of antibodies disappear after a month, “if you give twice as much, you will have two months’ protection,” Lilly’s Skovronsky said.— The big fear: Antibodies may do the opposite of what’s hoped and actually enhance the virus’s ability to get into cells or stimulate the immune system in a way that makes people sicker. It’s a theoretical concern that hasn’t been seen in testing so far, but large, definitive experiments are needed to prove safety.“As best as we can tell, the antibodies are helpful,” Lyon said.___Marilynn Marchione can be followed on Twitter: @MMarchioneAP___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5919

When Sen. Bernie Sanders did this in 2013, he did it alone.On Wednesday, nearly four years later, Sanders introduced a new "Medicare for all" health care bill with a third of the Senate Democratic caucus by his side.Flanked at first by New York Sen. Kirsten Gillibrand and Connecticut Sen. Richard Blumenthal, Sanders called the costs of the current system "insane and unaffordable," promising that the average family would benefit financially under his plan "because you will no longer be writing checks to private insurance companies."For those whose taxes would go up, he added, "that expense will be more than offset by the money are you are saving with the elimination of private insurance costs." 710

While the second Monday in October is traditionally when Columbus Day is observed, many communities have opted to celebrate Indigenous Peoples’ Day instead.Columbus Day became a federal holiday in 1937. For many, the holiday is a way of honoring the achievements of Christopher Columbus and celebrating Italian-American heritage, according the History Channel.However, the explorer and his holiday have generated controversy. Although Columbus was the first European to explore the Americas since the Vikings established colonies in the 10th century, the History Channel says he viewed the native people as obstacles.Columbus is accused of labeling the indigenous people as “Indians.” Other points of controversy revolve around the use of violence and slavery, the forced conversion of native people to Christianity, and the introduction of deadly diseases.As a result of these points, Native Americans and other groups have protested the celebration of Columbus Day, viewing it as a celebration of the colonization of America, the beginning of the slave trade, and the deaths of natives from murder and disease.In the past few years, there’s been a movement to replace Columbus Day with Indigenous Peoples’ Day, which honors Native American histories and cultures. Several states now celebrate or observe that holiday instead of or in conjunction with Columbus Day.A total of 14 states, Washington D.C. and more than 130 cities observe Indigenous Peoples’ Day, USA Today reports. Those states are Alabama, Alaska, Hawaii, Idaho, Maine, Michigan, Minnesota, New Mexico, North Carolina, Oklahoma, Oregon, South Dakota, Vermont and Wisconsin. 1648